Condition
Epicardial Fat
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Unknown2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07297589Phase 3Recruiting
Epicardial Cardiac Fat-CT (EPIC-CT)
NCT04200625CompletedPrimary
Semaglutide vs Dulaglutide on Epicardial Adipose Tissue
NCT03111693UnknownPrimary
CT Evaluation of Cardiovascular Risk Markers in Obese Patients
NCT01344694UnknownPrimary
Epicardial Fat, Visceral Fat and Coronary Atherosclerosis
Showing all 4 trials